Permuteins of interleukin 1 beta--a simplified approach for the construction of permutated proteins having new termini. |
| |
Authors: | R A Horlick H J George G M Cooke R J Tritch R C Newton A Dwivedi M Lischwe F R Salemme P C Weber R Horuk |
| |
Institution: | Du Pont Merck Pharmaceutical Co., Wilmington, DE 19880-0400. |
| |
Abstract: | A technique for the rapid and simple generation of permutated versions of the interleukin-1 beta (IL-1 beta) gene is described. In this method, the human IL-1 beta cDNA is twice amplified by the polymerase chain reaction (PCR) and the resulting DNA fragments are ligated in tandem. Between the two genes, the DNA sequence encodes a short four amino acid loop to link the native N- and C-terminal ends of the IL-1 beta protein. By using PCR amplification from this starting template, a new version of the IL-1 beta cDNA was obtained that encodes a permutated form of the IL-1 beta protein where the new N- and C-terminal amino acids correspond to residues 65 and 64 of the native IL-1 beta sequence, respectively. The name 'permutein' is proposed to describe proteins generated by this technology. The molecular profile (IL-1 receptor binding, biologic activity and solution properties) of the IL-1 permutein produced by this technology, permutein 65/64, is shown to be identical to that of native IL-1 beta. The approach should be useful to define further the structural features of this protein that are important for its function. |
| |
Keywords: | |
|
|